Stockscreener 앱 받기
1.15
3.60%
0.04
시간 외 거래:
1.16
0.01
+0.87%
전일 마감가:
$1.11
열려 있는:
$1.1
하루 거래량:
2.35M
Relative Volume:
0.61
시가총액:
$255.16M
수익:
$95,000
순이익/손실:
$-327.27M
주가수익비율:
-0.5425
EPS:
-2.12
순현금흐름:
$-239.25M
1주 성능:
+1.77%
1개월 성능:
+2.68%
6개월 성능:
-40.41%
1년 성능:
-54.18%
1일 변동 폭
$1.10
$1.18
1주일 범위
$1.06
$1.2065
52주 변동 폭
$0.8621
$3.78
Allogene Therapeutics Inc Stock (ALLO) Company Profile
명칭
Allogene Therapeutics Inc
전화
(650) 457-2700
주소
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
ALLO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALLO
Allogene Therapeutics Inc
|
1.15 | 246.29M | 95,000 | -327.27M | -239.25M | -2.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Allogene Therapeutics Inc Stock (ALLO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-14 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2024-08-08 | 재개 | Oppenheimer | Outperform |
| 2024-05-31 | 개시 | Piper Sandler | Overweight |
| 2024-01-05 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-01-05 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2023-12-08 | 개시 | Citigroup | Buy |
| 2023-06-26 | 재개 | Oppenheimer | Outperform |
| 2023-03-21 | 개시 | Bernstein | Mkt Perform |
| 2023-01-24 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-01-06 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2022-12-12 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2022-08-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2022-07-15 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-06-03 | 개시 | Robert W. Baird | Neutral |
| 2022-02-28 | 재확인 | B. Riley Securities | Buy |
| 2021-10-20 | 개시 | Cowen | Outperform |
| 2021-10-08 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-10-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-09-23 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2021-06-21 | 재개 | Jefferies | Buy |
| 2021-05-20 | 업그레이드 | Truist | Hold → Buy |
| 2021-05-14 | 개시 | B. Riley Securities | Buy |
| 2021-01-26 | 업그레이드 | Stifel | Hold → Buy |
| 2020-12-10 | 재개 | H.C. Wainwright | Buy |
| 2020-11-24 | 개시 | BofA Securities | Buy |
| 2020-10-23 | 개시 | RBC Capital Mkts | Outperform |
| 2020-06-01 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-05-29 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-19 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2020-05-15 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-05-14 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-14 | 다운그레이드 | SunTrust | Buy → Hold |
| 2020-04-13 | 개시 | SunTrust | Buy |
| 2020-03-13 | 개시 | H.C. Wainwright | Buy |
| 2020-03-05 | 개시 | Stifel | Hold |
| 2020-02-24 | 개시 | Berenberg | Hold |
| 2019-12-18 | 개시 | JMP Securities | Mkt Outperform |
| 2019-11-04 | 개시 | Canaccord Genuity | Buy |
| 2019-08-09 | 개시 | BTIG Research | Buy |
| 2019-06-05 | 개시 | ROTH Capital | Neutral |
| 2019-05-31 | 개시 | Guggenheim | Neutral |
| 2019-05-23 | 개시 | Stifel | Hold |
| 2019-03-29 | 개시 | Piper Jaffray | Overweight |
모두보기
Allogene Therapeutics Inc 주식(ALLO)의 최신 뉴스
Visual analytics tools that track Allogene Therapeutics Inc. performance2025 Earnings Impact & Fast Gaining Stock Reports - Newser
Why is Allogene Therapeutics Inc. stock going upEarnings Risk Report & Reliable Volume Spike Trade Alerts - خودرو بانک
Momentum divergence signals in Allogene Therapeutics Inc. chart2025 Dividend Review & Free Daily Entry Point Trade Alerts - Newser
Key metrics from Allogene Therapeutics Inc.’s quarterly dataPortfolio Update Report & Stepwise Entry/Exit Trade Alerts - Newser
How institutional ownership impacts Allogene Therapeutics Inc. stockJuly 2025 Fed Impact & Verified Momentum Watchlists - Newser
Is Allogene Therapeutics Inc. reversing from oversold territoryGap Up & Daily Oversold Bounce Ideas - Newser
Is it too late to sell Allogene Therapeutics Inc.2025 Risk Factors & Free Long-Term Investment Growth Plans - Newser
Can Allogene Therapeutics Inc. outperform under higher oil pricesBull Run & Daily Chart Pattern Signal Reports - خودرو بانک
Visualizing Allogene Therapeutics Inc. stock with heatmapsRate Cut & Daily Profit Maximizing Trade Tips - Newser
Volume spikes in Allogene Therapeutics Inc. stock – what they mean2025 Earnings Surprises & Verified Entry Point Signals - Newser
Using economic indicators to assess Allogene Therapeutics Inc. potentialMarket Volume Summary & Entry and Exit Point Strategies - Newser
Exit strategy if you’re trapped in Allogene Therapeutics Inc.July 2025 Levels & Precise Buy Zone Identification - Newser
Is Allogene Therapeutics Inc. stock influenced by commodity pricesLong Setup & Weekly Momentum Stock Picks - خودرو بانک
Order flow analysis tools used on Allogene Therapeutics Inc.Product Launch & Real-Time Stock Movement Alerts - Newser
Will Allogene Therapeutics Inc. outperform its industry peersJuly 2025 Big Picture & Daily Volume Surge Signals - خودرو بانک
Intraday pattern recognizer results for Allogene Therapeutics Inc.2025 Technical Patterns & Real-Time Volume Analysis Alerts - Newser
Allogene Therapeutics Inc. stock trendline breakdown2025 Support & Resistance & Momentum Based Trading Signals - Newser
Will Allogene Therapeutics Inc. benefit from current market trendsDividend Hike & Weekly Momentum Stock Picks - خودرو بانک
Will Allogene Therapeutics Inc. outperform the marketJuly 2025 Outlook & Safe Capital Preservation Plans - Newser
Can Allogene Therapeutics Inc. be the next market leaderWeekly Profit Recap & Capital Efficient Trading Techniques - خودرو بانک
Why Allogene Therapeutics Inc. is moving todayJobs Report & High Accuracy Trade Alerts - Newser
Real time pattern detection on Allogene Therapeutics Inc. stockMarket Growth Report & Reliable Price Breakout Alerts - Newser
What MACD signals say about Allogene Therapeutics Inc.2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - Newser
Should you hold or exit Allogene Therapeutics Inc. nowTrade Ideas & Low Risk Investment Opportunities - Newser
Should you wait for a breakout in Allogene Therapeutics Inc.2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - Newser
What earnings revisions data tells us about Allogene Therapeutics Inc.Weekly Trade Summary & Detailed Earnings Play Strategies - Newser
Has Allogene Therapeutics Inc. found a price floorJuly 2025 Highlights & Free Real-Time Market Sentiment Alerts - Newser
What momentum shifts mean for Allogene Therapeutics Inc.Weekly Trade Analysis & Low Drawdown Momentum Ideas - Newser
Allogene Therapeutics Inc. stock trend outlook and recovery pathWeekly Risk Report & AI Based Buy and Sell Signals - Newser
Allogene Therapeutics Inc. stock outlook for YEAREarnings Performance Report & Fast Entry Momentum Trade Alerts - Newser
Evaluating Allogene Therapeutics Inc. with trendline analysisPortfolio Profit Report & Smart Allocation Stock Tips - Newser
Is Allogene Therapeutics Inc. building a consolidation baseWeekly Trading Summary & Daily Profit Focused Stock Screening - Newser
Allogene Therapeutics’ SWOT analysis: stock faces challenges amid promising pipeline - Investing.com
Comparing Allogene Therapeutics Inc. in custom built stock radarsJuly 2025 Snapshot & Free High Accuracy Swing Entry Alerts - Newser
Panic Selling: Can Allogene Therapeutics Inc. sustain earnings growthPortfolio Gains Report & Risk Controlled Swing Alerts - خودرو بانک
Full technical analysis of Allogene Therapeutics Inc. stock2025 Market Outlook & Risk Managed Investment Signals - Newser
Backtesting results for Allogene Therapeutics Inc. trading strategiesJuly 2025 Macro Moves & Community Supported Trade Ideas - Newser
How to recover losses in Allogene Therapeutics Inc. stockTrade Ideas & Risk Managed Investment Entry Signals - Newser
Using Ichimoku Cloud for Allogene Therapeutics Inc. technicalsInflation Watch & Risk Controlled Stock Pick Alerts - Newser
How to manage a losing position in Allogene Therapeutics Inc.CPI Data & Reliable Breakout Forecasts - Newser
Allogene Therapeutics Inc (ALLO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):